1-bromo-3-((3-fluorobenzyl)oxy)benzene

Catalog No.: 
ACBIXA075
CAS No.: 
845866-57-1
Molecular Formula: 
C13H10BrFO
Molecular Weight: 
279.99
1-bromo-3-((3-fluorobenzyl)oxy)benzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$203.00In stockInquiry
25g95%$340.00InquiryInquiry
100g95%$1115.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-bromo-3-((3-fluorobenzyl)oxy)benzene
IUPAC Name1-bromo-3-((3-fluorobenzyl)oxy)benzene
MDL No.MFCD06411668
Molecular FormulaC13H10BrFO
Molecular Weight279.99
SMILESFC1=CC=CC(COC2=CC(Br)=CC=C2)=C1
InChI KeyFORGUMWHVBBXQD-UHFFFAOYSA-N
Synonym3-(3-FLUOROBENZYLOXY)-BROMOBENZENE;3-BROMOPHENYL-(3-FLUOROBENZYL)ETHER;Benzene, 1-bromo-3-[(3-fluorophenyl)methoxy]-
CAS No.845866-57-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBIXA075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKRAI035 route compound structure diagram
    ACKRAI035456-47-3In Stock
  4. Then
  5. ACBIXA075 route product structure diagram
    ACBIXA075845866-57-1In Stock
Inquiry

2. ACBIXA075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBIXA075 route product structure diagram
    ACBIXA075845866-57-1In Stock
Inquiry

3. ACBIXA075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBIXA075 route product structure diagram
    ACBIXA075845866-57-1In Stock
Inquiry

Comments (0)